15 of the most innovative EIC-backed companies on health and life sciences have been selected to take part in the new EIC USA Soft-landing programme. Since their selection, the EIC innovators follow a full preparatory business training to get ready for a Soft-landing week in San Francisco and Silicon Valley next 19-24May 2024.
The selected group of innovators will receive the support of high-level local domain experts and will have access to dedicated pitching and networking activities. There will be targeted market insights and warm introductions to the most relevant stakeholders within the San Francisco/Silicon Valley ecosystem including high level investors, corporates and other potential business partners.
The EIC USA Soft-landing is a business acceleration program for international companies who have launched and gained traction abroad and want to expand to a new big market without taking their attention away from their main operations at home.
For this second edition of programme, the EIC is partnering with its ambassador, experienced investor and entrepreneur, Jillian Manus, and with a group of high level business organisations including Stanford School of Medicine, INSEAD San Francisco Hub, Nasdaq Entrepreneurial Center, San Francisco Bay Area Council and the Commonwealth Club.
The 15 EIC-awardees selected are:
USA Soft-landing on Health - Pre-departure briefing
Learn more about the EIC ITF 3.0 programme:
The EIC International Trade Fairs & USA Soft-landing Programme 3.0 supports the internationalisation of European startups in continuity of the predecessor EIC Overseas Trade Fairs Programme OTF 2.0.
Stay tuned on upcoming calls and find additional information and the EIC Community Platform through our news, stories and ITF-related trade fairs.
Should you have any questions on the Programme, please do not hesitate to contact us through the EIC Community Helpdesk by selecting "EVENT - EIC ITF Programme – Soft-landing Silicon Valley 2024" as the subject in the "Category" field.
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.